NICE recommends new haemolytic anaemia treatment
European Pharmaceutical Review
MAY 3, 2024
The document also detailed that clinical evidence has shown that patients given voxelotor “are more likely to have an increase in haemoglobin levels compared with people who have usual treatment”. NICE’s decision follows a reduction in the price of voxelotor.
Let's personalize your content